Weill Cornell

New York, NY

Sorting 1 by

Accepting patients

VMD-928

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Learn more
  • Tyrosine Kinase (TK) Inhibitor
  • Phase 1/2